{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:37:44Z","timestamp":1793263064344,"version":"4.5.0"},"reference-count":36,"publisher":"BMJ","issue":"3","funder":[{"name":"UK Efficacy and Mechanism Evaluation Programme","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,11,3]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammatory subphenotypes have been identified in acute respiratory distress syndrome (ARDS). Hyperferritinaemia in sepsis is associated with hyperinflammation, worse clinical outcomes, and may predict benefit with immunomodulation. Our aim was to determine if raised ferritin identified a subphenotype in patients with ARDS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Baseline plasma ferritin concentrations were measured in patients with ARDS from two randomised controlled trials of simvastatin (Hydroxymethylglutaryl-CoA Reductase Inhibition with Simvastatin in Acute Lung Injury to Reduce Pulmonary Dysfunction-2 (HARP-2); discovery cohort, UK) and neuromuscular blockade (ROSE; validation cohort, USA). Results were analysed using a logistic regression model with restricted cubic splines, to determine the ferritin threshold associated with 28-day mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ferritin was measured in 511 patients from HARP-2 (95% of patients enrolled) and 847 patients (84% of patients enrolled) from ROSE. Ferritin was consistently associated with 28-day mortality in both studies and following a meta-analysis, a log-fold increase in ferritin was associated with an OR 1.71 (95% CI 1.01 to 2.90) for 28-day mortality. Patients with ferritin &gt;1380\u2009ng\/mL (HARP-2 28%, ROSE 24%) had a significantly higher 28-day mortality and fewer ventilator-free days in both studies. Mediation analysis, including confounders (acute physiology and chronic health evaluation-II score and ARDS aetiology) demonstrated a statistically significant contribution of interleukin (IL)-18 as an intermediate pathway between ferritin and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Ferritin is a clinically useful biomarker in ARDS and is associated with worse patient outcomes. These results provide support for prospective interventional trials of immunomodulatory agents targeting IL-18 in this hyperferritinaemic subgroup of patients with ARDS.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2023-220292","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T18:25:37Z","timestamp":1703615137000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-9306","authenticated-orcid":false,"given":"Puja","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romit J","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Mawhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G","family":"McAleavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-2538","authenticated-orcid":false,"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S","family":"Calfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Matthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-2873","authenticated-orcid":false,"given":"Charlotte","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1370-9417","authenticated-orcid":false,"given":"Rachel Clare","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Francis","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M","family":"O'Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"2024051409164370000_79.3.227.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669"},{"key":"2024051409164370000_79.3.227.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0291"},{"key":"2024051409164370000_79.3.227.3","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(16)00578-X","article-title":"Acute respiratory distress syndrome","volume":"388","author":"Sweeney","year":"2016","journal-title":"Lancet"},{"key":"2024051409164370000_79.3.227.4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024051409164370000_79.3.227.5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024051409164370000_79.3.227.6","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx031"},{"key":"2024051409164370000_79.3.227.7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"2024051409164370000_79.3.227.8","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the Hscore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024051409164370000_79.3.227.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0930-5","article-title":"Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis","volume":"15","author":"Kyriazopoulou","year":"2017","journal-title":"BMC Med"},{"key":"2024051409164370000_79.3.227.10","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2024051409164370000_79.3.227.11","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(20)30275-7","article-title":"COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study","volume":"2","author":"Manson","year":"2020","journal-title":"Lancet Rheumatology"},{"key":"2024051409164370000_79.3.227.12","doi-asserted-by":"crossref","unstructured":"Jia J , Wang M , Meng J , et al . Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset still\u2019s disease pathogenesis. Nat Commun 2022;13. doi:10.1038\/s41467-022-34560-7","DOI":"10.1038\/s41467-022-34560-7"},{"key":"2024051409164370000_79.3.227.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69031-w","article-title":"Pro-inflammatory properties of H-Ferritin on human macrophages, ex vivo and in vitro observations","volume":"10","author":"Ruscitti","year":"2020","journal-title":"Sci Rep"},{"key":"2024051409164370000_79.3.227.14","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.58"},{"key":"2024051409164370000_79.3.227.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0003OC"},{"key":"2024051409164370000_79.3.227.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-012-1409-3"},{"key":"2024051409164370000_79.3.227.17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0000000000003816","article-title":"Association of elevated plasma interleukin-18 level with increased mortality in a clinical trial of statin treatment for acute respiratory distress syndrome","volume":"47","author":"Rogers","year":"2019","journal-title":"Crit Care Med"},{"key":"2024051409164370000_79.3.227.18","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001402"},{"key":"2024051409164370000_79.3.227.19","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1164\/ajrccm.159.5.9809027","article-title":"Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome","volume":"159","author":"Sharkey","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051409164370000_79.3.227.20","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.1.9001283"},{"key":"2024051409164370000_79.3.227.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05561-y","article-title":"Novel risk scoring system for predicting acute respiratory distress syndrome among hospitalized patients with Coronavirus disease 2019 in Wuhan, China","volume":"20","author":"Liang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2024051409164370000_79.3.227.22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1515\/pteridines-2019-0021","article-title":"Serological ferritin, 100A12, procalcitonin and APACHEII score in prediction the prognosis of acute respiratory distress syndrome","volume":"30","author":"Chen","year":"2019","journal-title":"Pteridines"},{"key":"2024051409164370000_79.3.227.23","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04025-w","article-title":"Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial","volume":"26","author":"Boyle","year":"2022","journal-title":"Crit Care"},{"key":"2024051409164370000_79.3.227.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403285"},{"key":"2024051409164370000_79.3.227.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901686"},{"key":"2024051409164370000_79.3.227.26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"2024051409164370000_79.3.227.27","doi-asserted-by":"crossref","unstructured":"Harrell FE . Regression modelling strategies. With applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001.","DOI":"10.1007\/978-1-4757-3462-1"},{"key":"2024051409164370000_79.3.227.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0679-x"},{"key":"2024051409164370000_79.3.227.29","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.chest.2021.07.009","article-title":"Precision medicine and heterogeneity of treatment effect in therapies for ARDS","volume":"160","author":"Khan","year":"2021","journal-title":"Chest"},{"key":"2024051409164370000_79.3.227.30","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215950"},{"key":"2024051409164370000_79.3.227.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v100.i05","article-title":"Bayesian item response modeling in R with Brms and Stan","volume":"100","author":"B\u00fcrkner","year":"2021","journal-title":"J Stat Softw"},{"key":"2024051409164370000_79.3.227.32","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"2024051409164370000_79.3.227.33","first-page":"5751","article-title":"Clearance and tissue distribution of recombinant human interleukin 1 beta in rats","volume":"50","author":"Kudo","year":"1990","journal-title":"Cancer Res"},{"key":"2024051409164370000_79.3.227.34","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(90)91466-6"},{"key":"2024051409164370000_79.3.227.35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.13.2678"},{"key":"2024051409164370000_79.3.227.36","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209719"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-220292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:19:10Z","timestamp":1715703550000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-220292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2,15]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/thorax-2023-220292"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-220292","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}